Carter Bankshares vs Financial Institutions
CARE and FISI side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARE and FISI compare
Financial Institutions is the larger company, worth 1.2 times as much as Carter Bankshares ($770M against $635M).
On earnings, Carter Bankshares is cheaper: it trades at 4.8× trailing earnings, against 9.7× for Financial Institutions.
Carter Bankshares keeps more of each dollar of sales as profit, with a net margin of 50.0% compared with 32.4% at Financial Institutions.
Both pay dividends: Carter Bankshares yields 1.0% and Financial Institutions 3.2%.
Financial Institutions scores higher on the StockData Score (16 against 15 for Carter Bankshares), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARE | FISI |
|---|---|---|
| Size and price | ||
| Market cap | $635M | $770M |
| Share price | $28.67 | $39.09 |
| Change, 1 year | 63.5% | 33.6% |
| Change, 5 years | 96.4% | 25.7% |
| Beta (5Y) | −0.03 | 0.42 |
| Employees | 687 | 631 |
| StockData Score | ||
| Total score | 15 | 16 (better) |
| Valuation score | 6 (better) | 3 |
| Growth score | 1 (better) | 0 |
| Performance score | 3 | 5 (better) |
| Health score | 4 | 4 |
| Dividend score | 1 | 4 (better) |
| Valuation | ||
| P/E | 4.8× (better) | 9.7× |
| P/S | 2.4× (better) | 3.0× |
| P/B | 1.2× | 1.2× (better) |
| P/FCF | 13.1× (better) | 13.7× |
| PEG | – | 20.82 |
| FCF yield | 7.6% (better) | 7.3% |
| Fair value | $50.75 | $35.95 |
| Margin of safety | 43.5% (better) | −8.7% |
| Growth | ||
| Revenue growth (TTM) | 76.9% | – |
| Revenue growth, 5Y average | 2.5% | 6.1% (better) |
| Net income growth (TTM) | 320% | – |
| EPS growth (TTM) | 335% | – |
| EPS growth, 5Y average | – | 9.4% |
| Profitability | ||
| Net margin | 50.0% (better) | 32.4% |
| FCF margin | 18.5% | 22.1% (better) |
| Return on equity | 27.9% (better) | 13.3% |
| Financial health | ||
| Debt / equity | – | 0.28 |
| Altman Z-score | 0.29 (better) | 0.22 |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.0% | 3.2% (better) |
| Payout ratio | – | 30.2% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 3.6% |
| Buyback yield | – | 2.2% |
| Shareholder yield | 1.0% | 5.5% (better) |
| Ownership | ||
| Held by institutions | 65.5% | 79.8% |
| Held by insiders | 2.9% | 11.9% |
| Insider net buying, 12 months | −$253K | $108K (better) |
| Short interest, % of float | 11.2% | – |
Go deeper
- CARE stock overview
- CARE income statement
- CARE valuation and score
- FISI stock overview
- FISI income statement
- FISI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.